PhysIQ Closes $8 Million in Series B Financing | Read the press release here.

Who We Are

The physIQ team has been successfully developing highly innovative solutions for monitoring the health of complex systems for more than a decade.  Our core management team members are pioneers of IoT, with unparalled experience in developing and commercializing transformational machine-learning analytics for time-series sensor data...

James Koziarz, PhD


Dr. Koziarz is President and CEO of Rubicon Genomics, a leader in the commercialization of preanalytical processes to improve the performance and capabilities of analytical platforms for research and clinical testing. Previously he worked for 25 years in the Diagnostics Division of Abbott Laboratories, including 12 years as a corporate officer where he managed groups involved in product development, manufacturing and customer technical support, and new technology management. Since retirement from Abbott, he has been an active member of the entrepreneurial and venture communities, serving as an advisor to PhysIQ and several early stage, venture-backed life sciences companies. Prior to joining Abbott in 1979, Jim was a postdoctoral fellow in biochemistry at the University of Chicago. He earned a B.S. in chemistry from DePaul University, a PhD in biochemistry from the University of Chicago and won a National Research Service Award as a postdoctoral fellow.

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners, or anyone with an interest in learning more about the transformative potential of our technology.

CONTACT US